Shutterstock
Ludovic Brellier, President Biotechnology Integrated Solutions & Business Operations at Cytiva.
The biopharma industry has made minor strides toward improved resilience, but it’s not enough to meet future global demand for novel therapeutics. However, Ludovi Brellier, shows how to get there.
Shutterstock
Ludovic Brellier, President Biotechnology Integrated Solutions & Business Operations at Cytiva.
The week's biggest stories from this industry, direct to your inbox.